KR100200438B1 - 3,9-디아자비시클로(3,3.1) 노난-7-일 유도체, 이들의 제조를 위한 방법 및 중간체 및 이들을 함유한 제약학적 조성물 - Google Patents

3,9-디아자비시클로(3,3.1) 노난-7-일 유도체, 이들의 제조를 위한 방법 및 중간체 및 이들을 함유한 제약학적 조성물 Download PDF

Info

Publication number
KR100200438B1
KR100200438B1 KR1019930700921A KR930700921A KR100200438B1 KR 100200438 B1 KR100200438 B1 KR 100200438B1 KR 1019930700921 A KR1019930700921 A KR 1019930700921A KR 930700921 A KR930700921 A KR 930700921A KR 100200438 B1 KR100200438 B1 KR 100200438B1
Authority
KR
South Korea
Prior art keywords
alkyl
hydrogen
compound
formula
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019930700921A
Other languages
English (en)
Korean (ko)
Other versions
KR930702345A (ko
Inventor
프랜시스데이빗킹
앤소니 그레고리 쥴리언
Original Assignee
데이빗 로버츠
비이참 그루우프 피이엘시이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이빗 로버츠, 비이참 그루우프 피이엘시이 filed Critical 데이빗 로버츠
Publication of KR930702345A publication Critical patent/KR930702345A/ko
Application granted granted Critical
Publication of KR100200438B1 publication Critical patent/KR100200438B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019930700921A 1990-09-26 1993-03-26 3,9-디아자비시클로(3,3.1) 노난-7-일 유도체, 이들의 제조를 위한 방법 및 중간체 및 이들을 함유한 제약학적 조성물 Expired - Lifetime KR100200438B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909020927A GB9020927D0 (en) 1990-09-26 1990-09-26 Pharmaceuticals
GB9020927.1 1990-09-26
PCT/GB1991/001629 WO1992005174A1 (en) 1990-09-26 1991-09-23 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
KR930702345A KR930702345A (ko) 1993-09-08
KR100200438B1 true KR100200438B1 (ko) 1999-06-15

Family

ID=10682769

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700921A Expired - Lifetime KR100200438B1 (ko) 1990-09-26 1993-03-26 3,9-디아자비시클로(3,3.1) 노난-7-일 유도체, 이들의 제조를 위한 방법 및 중간체 및 이들을 함유한 제약학적 조성물

Country Status (18)

Country Link
EP (1) EP0550550B1 (enExample)
JP (1) JP2831464B2 (enExample)
KR (1) KR100200438B1 (enExample)
AT (1) ATE245157T1 (enExample)
AU (1) AU652187B2 (enExample)
CA (1) CA2092431C (enExample)
CY (1) CY2387B1 (enExample)
DE (1) DE69133295T2 (enExample)
DK (1) DK0550550T3 (enExample)
ES (1) ES2203609T3 (enExample)
GB (1) GB9020927D0 (enExample)
IE (1) IE913352A1 (enExample)
MX (1) MX9101236A (enExample)
NZ (1) NZ239915A (enExample)
PT (1) PT99028B (enExample)
TW (1) TW240227B (enExample)
WO (1) WO1992005174A1 (enExample)
ZA (1) ZA917606B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121170D0 (en) * 1991-10-05 1991-11-20 Smithkline Beecham Plc Pharmaceuticals
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
US5514690A (en) * 1992-11-17 1996-05-07 E. R. Squibb & Sons, Inc. Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
PL372141A1 (en) 2002-04-29 2005-07-11 Actelion Pharmaceuticals Ltd. 7-aryl-3,9-diazabicyclo[3.3.1]non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
JP2007508262A (ja) * 2003-10-13 2007-04-05 アクテリオン　ファマシューティカルズ　リミテッド 新規ジアザビシクロノネン誘導体およびその使用
EA200801607A1 (ru) 2004-06-15 2008-10-30 Пфайзер Инк. Производные бензимидазолонкарбоновой кислоты
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
BRPI0607456A2 (pt) 2005-02-22 2009-09-08 Pfizer derivados de oxindol como agonistas do receptor 5ht4
US8129538B1 (en) 2007-03-28 2012-03-06 Takeda Pharmaceutical Company Limited Renin inhibitors
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0498466B1 (en) * 1985-04-27 2002-07-24 F. Hoffmann-La Roche Ag Indazole-3-carboxamide and -3-carboxylic acid derivatives
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
US4920227A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Benzobicyclic carboxamide 5-HT3 antagonists
US4920219A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents

Also Published As

Publication number Publication date
NZ239915A (en) 1993-11-25
DE69133295T2 (de) 2004-03-18
ES2203609T3 (es) 2004-04-16
AU8624491A (en) 1992-04-15
ATE245157T1 (de) 2003-08-15
CA2092431A1 (en) 1992-03-27
ZA917606B (en) 1992-09-30
JPH06501256A (ja) 1994-02-10
GB9020927D0 (en) 1990-11-07
PT99028A (pt) 1993-10-29
WO1992005174A1 (en) 1992-04-02
KR930702345A (ko) 1993-09-08
EP0550550A1 (en) 1993-07-14
JP2831464B2 (ja) 1998-12-02
EP0550550B1 (en) 2003-07-16
HK1012356A1 (en) 1999-07-30
AU652187B2 (en) 1994-08-18
DE69133295D1 (de) 2003-08-21
MX9101236A (es) 1992-05-04
TW240227B (enExample) 1995-02-11
CA2092431C (en) 2002-12-10
PT99028B (pt) 1999-02-26
DK0550550T3 (da) 2003-09-08
IE913352A1 (en) 1992-04-08
CY2387B1 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
AP401A (en) Condensed indole derivatives as 5H4-receptor antagonists.
KR100200438B1 (ko) 3,9-디아자비시클로(3,3.1) 노난-7-일 유도체, 이들의 제조를 위한 방법 및 중간체 및 이들을 함유한 제약학적 조성물
EP0255297B1 (en) Azabicyclic compounds, process for their preparation, and their pharmaceutical use
AU626614B2 (en) 9-aza-3(oxa or thio)bicyclo(3.3.1)nonane derivatives
EP0254584B1 (en) Azabicyclic compounds, process for their preparation, and their pharmaceutical use
JPH11503143A (ja) ５ｈｔ▲下１ｄ▼ アンタゴニストとしてのビフェニルアミド誘導体
EP0289170B1 (en) Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
AU4830593A (en) 5-ht4 antagonists
EP0261964A2 (en) Azabicyclic compounds and their use as 5-ht3 receptor antagonists
WO1994008965A1 (en) N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
JP2008530234A (ja) Ｃｉｎｖ及びｉｂｓ−ｄ治療用のベンゾオキサゾールカルボキサミド
WO1993018027A1 (en) Nitrogen containing heterocyclic compounds useful as pharmaceuticals
AU5150393A (en) Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists
EP0226267B1 (en) Oxa-, thia- and diazabicycloalkane derivatives, process for their preparation and their use as pharmaceuticals
CA2098729A1 (en) Azabicyclic amides or esters of halogenated benzoic acids
EP0607233A1 (en) 3,9-diazabicyclo(3.3.1)nonane derivatives with 5-ht3 receptor antagonist activity
HK1012356B (en) 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
EP0611370A1 (en) Pyridine-3-carboxylic acid esters or amides useful as 5-ht 3? antagonists

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930325

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19960923

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930325

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19981029

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990127

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19990310

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19990311

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20020128

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20030123

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20040113

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20050114

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20060113

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20070112

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20080117

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20090121

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20100122

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20110225

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20110225

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20121009

Termination category: Expiration of duration